BLOG

empowered

Getting Across Tissue Barriers for Precise Delivery of Drugs with Jeff Cleland Ashvattha Therapeutics

Jeff Cleland is the Chairman, President, and CEO of Ashvattha Therapeutics, initially focusing on demonstrating the ability to deliver drugs that cross tissue barriers like the blood-brain barrier and the blood-retinal barrier to attack inflammation.